Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Core Insights - Caris Life Sciences will report its third quarter 2025 financial results on November 5, 2025, and will host a conference call at 3:30 p.m. CT [1] - The company is recognized as a leading, patient-centric, next-generation AI TechBio firm and a pioneer in precision medicine [2] Company Overview - Caris Life Sciences specializes in developing and commercializing innovative healthcare solutions through comprehensive molecular profiling and advanced AI and machine learning algorithms [2] - The company has established a large-scale, multimodal clinico-genomic database to analyze the molecular complexity of diseases, enhancing precision medicine diagnostic solutions [2] - Founded with the vision to improve the human condition through precision medicine, Caris is headquartered in Irving, Texas, with additional offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan, and Basel, Switzerland [2]